PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Cardiology, Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai, China.\', \'Department of Gastroenterology and Hepatology, Shanghai Public Health Clinical Center, Fudan University, Shanghai, China.\', \'Department of Gastroenterology and Hepatology, Shanghai Public Health Clinical Center, Fudan University, Shanghai, China. Electronic address: chengjilin@shphc.org.cn.\', \'Department of Cardiology, Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai, China. Electronic address: fanminyueyang@outlook.com.\']
?:citedBy
  • -1
?:creator
?:doi
  • S0025-7753(20)30362-610.1016/j.medcli.2020.06.007
?:doi
?:hasPublicationType
?:journal
  • Medicina clinica
is ?:pmid of
?:pmid
?:pmid
  • 32747012
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 0.262
?:rankingScore_hIndex
  • 61
is ?:relation_isRelatedTo_publication of
?:title
  • The effects of renin-angiotensin system inhibitors (RASI) in coronavirus disease (COVID-19) with hypertension: A retrospective, single-center trial.
?:type
?:year
  • 2020

Metadata

Anon_0  
expand all